{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-092491","form_type":"8-K","ticker":"GRDX","cik":"0001604191","company_name":"GridAI Technologies Corp.","filed_at":"2024-08-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.736784+00:00","generated_at":"2026-05-31T07:51:01.565815+00:00","sec_items":["3.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Entero Therapeutics receives Nasdaq non-compliance notice for late Form 10-Q filing","bullets":["Nasdaq notice on Aug 21, 2024, for failure to timely file Q2 2024 Form 10-Q.","Company has 60 days (until Oct 21, 2024) to submit compliance plan; possible extension to Feb 17, 2025.","Forvis Mazars resigned as auditor on Aug 9, 2024; company seeking new independent accounting firm.","Notice has no immediate effect on Nasdaq listing, but delisting risk if compliance not regained."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-092491","json":"https://secwatch.observer/filing/0001104659-24-092491.json","markdown":"https://secwatch.observer/filing/0001104659-24-092491.md","text":"https://secwatch.observer/filing/0001104659-24-092491.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924092491/0001104659-24-092491-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924092491/tm2422567d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T07:51:01.565815+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}